cd138 plasma cell isolation kit (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
94
Structured Review
Miltenyi Biotec
cd138 plasma cell isolation kit
Cd138 Plasma Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasma+cell+isolation/CD138%2B+Plasma+Cell+Isolation+Kit%2C+mouse/us12698321-1147-11-9
Average 94 stars, based on 20 article reviews
Cd138 Plasma Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasma+cell+isolation/CD138%2B+Plasma+Cell+Isolation+Kit%2C+mouse/us12698321-1147-11-9
Average 94 stars, based on 20 article reviews
cd138 plasma cell isolation kit - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. Article Snippet: .. Article Title: C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma Article Snippet: .. Article Title: Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients. Article Snippet: CD138 MicroBeads (Miltenyi Biotec, Cologne, Bergischladbach, Germany) were used for the positive selection of plasma cells from the bone marrow samples. .. All the experiment procedures of Article Title: Methods of determining IMiDS resistance in plasma cell disorders Article Snippet: Samples were hybridized to Affymetrix expression arrays. .. Article Title: CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival Article Snippet: .. Article Title: PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma. Article Snippet: Multiple myeloma (MM) patients commonly present abnormal expression of cancer–testis antigens, which may serve as immunotherapeutic targets and prognostic factors.. We previously reported that preferentially expressed antigen of melanoma (PRAME) overexpression in bone marrow mononuclear cells is related to progression in MM patients treated with non-bortezomib-containing regimens.. The mechanism underlying variations in PRAME expression remains unknown. Article Title: Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome. Article Snippet: .. Cell Isolation:Article Title: Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. Article Snippet: .. Article Title: C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma Article Snippet: .. Article Title: Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients. Article Snippet: CD138 MicroBeads (Miltenyi Biotec, Cologne, Bergischladbach, Germany) were used for the positive selection of plasma cells from the bone marrow samples. .. All the experiment procedures of Article Title: Methods of determining IMiDS resistance in plasma cell disorders Article Snippet: Samples were hybridized to Affymetrix expression arrays. .. Article Title: CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival Article Snippet: .. Article Title: PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma. Article Snippet: Multiple myeloma (MM) patients commonly present abnormal expression of cancer–testis antigens, which may serve as immunotherapeutic targets and prognostic factors.. We previously reported that preferentially expressed antigen of melanoma (PRAME) overexpression in bone marrow mononuclear cells is related to progression in MM patients treated with non-bortezomib-containing regimens.. The mechanism underlying variations in PRAME expression remains unknown. Article Title: Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome. Article Snippet: .. Purification:Article Title: Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. Article Snippet: .. Magnetic Beads:Article Title: Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations. Article Snippet: .. Ex Vivo:Article Title: C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma Article Snippet: .. Isolation:Article Title: C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma Article Snippet: .. Article Title: CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival Article Snippet: .. Article Title: Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome. Article Snippet: .. Selection:Article Title: Methods of determining IMiDS resistance in plasma cell disorders Article Snippet: Samples were hybridized to Affymetrix expression arrays. .. DNA Extraction:Article Title: PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma. Article Snippet: Multiple myeloma (MM) patients commonly present abnormal expression of cancer–testis antigens, which may serve as immunotherapeutic targets and prognostic factors.. We previously reported that preferentially expressed antigen of melanoma (PRAME) overexpression in bone marrow mononuclear cells is related to progression in MM patients treated with non-bortezomib-containing regimens.. The mechanism underlying variations in PRAME expression remains unknown. other:Article Title: Methods of determining IMiDS resistance in plasma cell disorders Article Snippet: Samples were hybridized to an Affymetrix U133Plus2.0 microarray for pomalidomide study and to an Affymetrix U95Av2 microarray for thalidomide and lenalidomide studies according to the manufacturer's recommendations and then read on GeneChip Scanner 3000 (Affymetrix). |